INCYTE CORP

(INCY)

CIK 879169 · SEC filings only

Not yet gradedGuidance record
harness minimum not met

company entity

0 resolved promises

Sector median (Industrial Applications and Services): B+ across 28 graded companies

Not enough comparable guidance to grade

0 of the 4 resolved guidance promises needed to publish a reliability grade. Some of this company’s guidance has no reported figure we can compare it with. It is shown below, never scored; the line under each statement says why. Here's what we're tracking — we never show a grade we can't back with receipts.

Pro

guidance history

Free scorecards show the 12 most recent resolved guidance promises. See the complete multi-year record with Pro.

See Pro →

Guidance by basis

No guidance figure from this company has been graded or dropped for basis yet.

Guidance type	Said	Graded	Dropped	Other
Revenue · basis not stated	17	0	0	17

Said counts every revenue and EPS guidance figure on record. Dropped counts figures whose period was reported but which have no comparable GAAP actual in SEC XBRL. Other covers open, superseded, withdrawn and otherwise unresolved figures. The coverage note below counts every figure shown but not graded, including figures whose period has not been reported, so it can be larger.

How the site-wide rate is measured

Compare across companies

Guidance shown, not graded (17)

We show what was said — with its source filing — but never score it. The line under each statement says why.

revenue guidance fy · Aug 2, 2022
Jakafi net product revenues $2.36 - $2.40 billion
Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
revenue guidance fy · Aug 2, 2022
Other Hematology/Oncology net product revenues (1) $210 - $240 million
Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
revenue guidance fy · May 3, 2022
Jakafi net product revenues $2.33 - $2.40 billion
Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
revenue guidance fy · Feb 8, 2022
Jakafi net product revenues $2.3 - $2.4 billion
Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
revenue guidance fy · Feb 8, 2022
Other Hematology/Oncology net product revenues (1) $210 - $240 million
Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
revenue guidance fy · Nov 2, 2021
Other Hematology/Oncology net product revenues $155 - $170 million
Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
revenue guidance fy · Nov 2, 2021
Jakafi net product revenues $2,125 - $2,170 million
Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
revenue guidance fy · Aug 3, 2021
Jakafi net product revenues $2,125 - $2,170 million
Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
revenue guidance fy · Aug 3, 2021
Other Hematology/Oncology net product revenues $155 - $170 million
Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
revenue guidance fy · May 4, 2021
Other Hematology/Oncology net product revenues $145 - $160 million
Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
revenue guidance fy · May 4, 2021
Jakafi net product revenues $2,125 - $2,200 million
Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
revenue guidance fy · Feb 9, 2021
Other Hematology/Oncology net product revenues $145 - $160 million
Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
revenue guidance fy · Feb 9, 2021
Jakafi net product revenues $2,125 - $2,200 million
Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
revenue guidance fy · Nov 5, 2020
Jakafi net product revenues $1,910 - $1,940
Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
revenue guidance fy · Nov 5, 2020
Iclusig net product revenues $100 - $105
Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
revenue guidance fy · Apr 30, 2019
GAAP and Non-GAAP Iclusig net product revenues $90 - $100 million
Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
revenue guidance fy · Apr 30, 2019
reaffirming full year 2019 revenue guidance range of $1.58-1.65 billion
Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗